Ketamine for the treatment of acute pain
| Autor: | Jonathan S. Zipursky, William K. Silverstein, David N. Juurlink |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Analgesics
Dose-Response Relationship Drug business.industry Dissociative anesthesia Low dose Contraindications Drug General Medicine Opioid-Related Disorders Acute Pain Analgesics Opioid Anesthesia Medicine Humans Ketamine Drug Therapy Combination Patient Safety business Phencyclidine Acute pain medicine.drug |
| Zdroj: | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 193(43) |
| ISSN: | 1488-2329 |
| Popis: | Ketamine is a phencyclidine (PCP) derivative that exerts its effects primarily through N -methyl-d-aspartate receptor inhibition.[1][1] At low doses (0.1–0.3 mg/kg), ketamine produces mainly analgesia. Dissociative anesthesia and psychomimetic effects occur with higher doses (≥ 1.0 mg/kg). Low |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|